An AI, err ma­chine learn­ing, shop lines up Eli Lil­ly as part­ner ahead of first in-house clin­i­cal tri­al

Life sci­ences soft­ware de­vel­op­er and drug dis­cov­ery out­fit Schrödinger, dur­ing its “plat­form day,” out­lined its pro­grams and path for­ward two months af­ter bring­ing on board …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER